Expression of macrophage antigens by tumor cells

Advances in Experimental Medicine and Biology

Volumn 950, Issue , 2011, Pages 141-150

  Shabo, Ivan ^a   Svanvik, Joar ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; CD68 ANTIGEN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; LYMPHOCYTE ANTIGEN; MAC387 ANTIGEN; UNCLASSIFIED DRUG; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROBP PROTEIN, HUMAN;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER RECURRENCE; CANCER SURVIVAL; EXOSOME; LIVER METASTASIS; MACROPHAGE; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECTUM CANCER; ANIMAL; CELL FUSION; HUMAN; IMMUNOLOGY; NEOPLASM; PATHOLOGY; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL FUSION; HUMANS; MACROPHAGES; MEMBRANE PROTEINS; NEOPLASMS; RECEPTORS, CELL SURFACE;

EID: 79960899892     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-0782-5_7     Document Type: Article

References (67)

1. Mantovani A, Bottazzi B, Colotta F, et al. (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265-270
2. Mantovani A, Schioppa T, Biswas SK, et al. (2003) Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations. Tumori 89:459-468 (Pubitemid 37541598)
3. Mantovani A, Schioppa T, Porta C, et al. (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25:315-322 (Pubitemid 44922352)
4. Mantovani A, Sozzani S, Locati M, et al. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555 (Pubitemid 35223554)
5. Martinez FO, Sica A, Mantovani A, et al. (2008) Macrophage activation and polarization. Front Biosci 13:453-461 (Pubitemid 351599757)
6. Vignery A (2005) Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med 202:337-340 (Pubitemid 41126949)
7. Larizza L, Schirrmacher V, Graf L, et al. (1984) Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma eb is derived from spontaneous fusion with a host macrophage. Int J Cancer 34:699-707 (Pubitemid 15207013)
8. Larizza L, Schirrmacher V, Pfluger E (1984) Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage. J Exp Med 160:1579-1584 (Pubitemid 15220784)
9. Munzarova M, Lauerova L, Capkova J (1992) Are advanced malignant melanoma cells hybrids between melanocytes and macrophages? Melanoma Res 2:127-129
10. Munzarova M, Lauerova L, Kovarik J, et al. (1992) Fusion-induced malignancy? A preliminary study. (A challenge to todays common wisdom). Neoplasma 39:79-86
11. Munzarova M, Zemanova D (1992) Transformation of blood monocytes to multinucleated giant cells in vitro: are there any differences between malignant and nonmalignant states? Physiol Res 41:221-226
12. Busund LT, Killie MK, Bartnes K, et al. (2002) Spontaneously formed tumorigenic hybrids of meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor. Int J Cancer 100:407-413
13. Pawelek JM, Chakraborty AK, Rachkovsky ML, et al. (1999) Altered N-glycosylation in macrophage × melanoma fusion hybrids. Cell Mol Biol (Noisy-Le-Grand) 45:1011-1027
14. Pawelek JM (2000) Tumour cell hybridization and metastasis revisited. Melanoma Res 10:507-514 (Pubitemid 32011972)
15. Chakraborty AK, Sodi S, Rachkovsky M, et al. (2000) A spontaneous murine melanoma lung metastasis comprised of host × tumor hybrids. Cancer Res 60:2512-2519 (Pubitemid 30262446)
16. Chakraborty AK, Pawelek J, Ikeda Y, et al. (2001) Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis. Cell Growth Differ 12:623-630 (Pubitemid 34084115)
17. Chakraborty AK, de Freitas Sousa J, Espreafico EM, et al. (2001) Human monocyte × mouse melanoma fusion hybrids express human gene. Gene 275:103-106 (Pubitemid 32907331)
18. Nygren JM, Jovinge S, Breitbach M, et al. (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10:494-501 (Pubitemid 38667908)
19. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. (2003) Fusion of bone-marrow-derived cells with purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968-973 (Pubitemid 37376928)
20. Mortensen K, Lichtenberg J, Thomsen PD, et al. (2004) Spontaneous fusion between cancer cells and endothelial cells. Cell Mol Life Sci 61:2125-2131 (Pubitemid 39149901)
21. Terada N, Hamazaki T, Oka M, et al. (2002) Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416:542-545 (Pubitemid 34288856)
22. Johansson CB, Youssef S, Koleckar K, et al. (2008) Extensive fusion of haematopoietic cells with purkinje neurons in response to chronic inflammation. Nat Cell Biol 10:575-583 (Pubitemid 351627377)
23. Pawelek JM, Chakraborty AK (2008) Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8:377-386 (Pubitemid 351589699)
24. Shabo I, Olsson H, Sun XF, et al. (2009) Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer 125:1826-1831
25. Shabo I, Stal O, Olsson H, et al. (2008) Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer 123:780-786 (Pubitemid 352032402)
26. Ziegler-Heitbrock HW, Ulevitch RJ (1993) CD14: cell surface receptor and differentiation marker. Immunol Today 14:121-125 (Pubitemid 23068296)
27. Bazil V, Baudys M, Hilgert I, et al. (1989) Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol 26:657-662 (Pubitemid 19188482)
28. Kirkland TN, Viriyakosol S (1998) Structure-function analysis of soluble and membrane-bound CD14. Prog Clin Biol Res 397:79-87
29. Viriyakosol S, Mathison JC, Tobias PS, et al. (2000) Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide. J Biol Chem 275:3144-3149 (Pubitemid 30083012)
30. Peterson PK, Gekker G, Hu S, et al. (1995) CD14 receptor-mediated uptake of nonopsonized mycobacterium tuberculosis by human microglia. Infect Immun 63:1598-1602
31. Tamai R, Sakuta T, Matsushita K, et al. (2002) Human gingival CD14(+) fibroblasts primed with gamma interferon increase production of interleukin-8 in response to lipopolysaccharide through up-regulation of membrane CD14 and MyD88 mRNA expression. Infect Immun 70:1272-1278 (Pubitemid 34163401)
32. Frey EA, Miller DS, Jahr TG, et al. (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176:1665-1671
33. Pugin J, Ulevitch RJ, Tobias PS (1993) A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med 178:2193-2200 (Pubitemid 23344877)
34. Saito N, Pulford KA, Breton-Gorius J, et al. (1991) Ultrastructural localization of the CD68 macrophage-associated antigen in human blood neutrophils and monocytes. Am J Pathol 139:1053-1059
35. Holness CL, da Silva RP, Fawcett J, et al. (1993) Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. J Biol Chem 268:9661-9666 (Pubitemid 23146025)
36. Holness CL, Simmons DL (1993) Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81:1607-1613 (Pubitemid 23083842)
37. Kurushima H, Ramprasad M, Kondratenko N, et al. (2000) Surface expression and rapid internalization of macrosialin (mouse CD68) on elicited mouse peritoneal macrophages. J Leukoc Biol 67:104-108 (Pubitemid 30046824)
38. Ramprasad MP, Terpstra V, Kondratenko N, et al. (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 93:14833-14838 (Pubitemid 26419055)
39. Khazen W, MBika J-P, Tomkiewicz C, et al. (2005) Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Letters 579:5631-5634 (Pubitemid 41455641)
40. Kunisch E, Fuhrmann R, Roth A, et al. (2004) Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 63: 774-784 (Pubitemid 38850447)
41. Doussis IA, Gatter KC, Mason DY (1993) CD68 reactivity of non-macrophage derived tumours in cytological specimens. J Clin Pathol 46:334-336 (Pubitemid 23138747)
42. Gloghini A, Rizzo A, Zanette I, et al. (1995) KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas. Am J Clin Pathol 103:425-431
43. Facchetti F, Bertalot G, Grigolato PG (1991) KP1 (CD 68) staining of malignant melanomas. Histopathology 19:141-145
44. Cassidy M, Loftus B, Whelan A, et al. (1994) KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. Virchows Arch 424:635-640 (Pubitemid 24245335)
45. Strojnik T, Kavalar R, Zajc I, et al. (2009) Prognostic impact of CD68 and kallikrein 6 in human glioma. Anticancer Res 29:3269-3279
46. Ribé A, McNutt NS (2003) S100A protein expression in the distinction between lentigo maligna and pigmented actinic keratosis. Am J Dermatopathol 25:93-99 (Pubitemid 36350453)
47. Loftus B, Loh LC, Curran B, et al. (1991) Mac387: its non-specificity as a tumour marker or marker of histiocytes. Histopathology 19:251-255
48. Lopez-Beltran A, Requena MJ, Alvarez-Kindelan J, et al. (2007) Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. J Clin Pathol 60:332-335 (Pubitemid 46447757)
49. Fabriek BO, Dijkstra CD, van den Berg TK (2005) The macrophage scavenger receptor CD163. Immunobiology 210:153-160 (Pubitemid 41025156)
50. KristiansenM, Graversen JH, Jacobsen C, et al. (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198-201 (Pubitemid 32144285)
51. Nguyen TT, Schwartz EJ, West RB, et al. (2005) Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol 29:617-624 (Pubitemid 40577871)
52. Stover CM, Schleypen J, Gronlund J, et al. (2000) Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 By in situ hybridization and somatic cell hybrid analysis. Cytogenet Cell Genet 90:246-247 (Pubitemid 32008772)
53. Pioli PA, Goonan KE, Wardwell K, et al. (2004) TGF-beta regulation of human macrophage scavenger receptor CD163 is smad3-dependent. J Leukoc Biol 76:500-508 (Pubitemid 39006966)
54. Ritter M, Buechler C, Langmann T, et al. (1999) The scavenger receptor CD163: regulation, promoter structure and genomic organization. Pathobiology 67:257-261 (Pubitemid 30135918)
55. Sulahian TH, Hogger P,Wahner AE, et al. (2000) Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12:1312-1321
56. Komohara Y, Hirahara J, Horikawa T, et al. (2006) AM-3 k, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J Histochem Cytochem 54:763-771 (Pubitemid 43946243)
57. Sica A, Schioppa T, Mantovani A, et al. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717-727
58. Shabo I, Olsson H, Sun XF, et al. (2009) Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer 125:1826-1831
59. Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987
60. Jensen TO, Schmidt H, Steiniche T, et al. (2010) Melanoma cell expression of macrophage markers in AJCC stage I/II melanoma. J Clin Oncol (Meeting Abstracts) 28:e19034
61. Kaifu T, Nakahara J, Inui M, et al. (2003) Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 111:323-332 (Pubitemid 36182208)
62. Paloneva J, Mandelin J, Kiialainen A, et al. (2003) DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 198:669-675 (Pubitemid 37045349)
63. Lucas M, Daniel L, Tomasello E, et al. (2002) Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice. Eur J Immunol 32:2653-2663
64. Ivashkiv LB (2009) Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol 10:340-347
65. Vivier E, Nunes JA, Vely F (2004) Natural killer cell signaling pathways. Science 306:1517-1519 (Pubitemid 39564941)
66. Bakker AB, Hoek RM, Cerwenka A, et al. (2000) DAP12-deficient mice fail to develop autoimmunity Due To impaired antigen priming. Immunity 13:345-353
67. Valadi H, Ekstrom K, Bossios A, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659 (Pubitemid 47214727)